<DOC>
	<DOCNO>NCT01048385</DOCNO>
	<brief_summary>The goal research increase live birth rate infertile woman reduce incidence aneuploidy lead miscarriage trisomy . We hypothesize age relate mitochondrial dysfunction reduces availability energy oocyte contribute abnormal segregation chromosome meiotic division lead oocyte aneuploidy . Based preliminary evidence obtain aged mouse , propose dietary supplementation Co enzyme Q10 old woman improve mitochondrial function oocyte , lead decrease chromosomal non-disjunction result embryos normal chromosomal complement . Our primary outcome measure determination oocyte chromosome number multiplex PCR base assay polar body biopsied time IVF . Outcomes proposal enable u address mechanism ovarian age may explain etiology decrease fertility old patient . In addition , work add feasibility single embryo transfer , thereby avoid multiple pregnancy associate cost health care system society .</brief_summary>
	<brief_title>The Effect Co Enzyme Q10 Together With Fertility Drugs Pregnancy Outcome Vitro Fertilization</brief_title>
	<detailed_description>The objective study evaluate efficacy CoQ10 administration respect effect rate aneuploidy oocytes cumulative live birth rate . Study Design This prospective randomize placebo control study . Study participant undergo 3 cycle part protocol . All clinical assessment conduct participate infertility clinic . The study organize outpatient basis Toronto Centre Advanced Reproductive Technology ( TCART ) . The study involve 54 woman age 35-43 year undergoing IVF treatment . All woman collect 2 mL saliva 5 mL polyethylene tube baseline measurement coQ10 activity arNOX assay ( describe ) . Study participant randomly assign either placebo COQ10 capsule , ( AOR - Advanced Orthomolecular Research Inc. 19 St NE Calgary , Alberta , NHPD registration code 135307 ) . Study participant take 600 mg CoQ10 orally day breakfast identical placebo capsule 2 month prior IVF cycle 3 cycle pregnancy occur . On cycle day 3 , subject start ovarian stimulation vitro fertilization continue consumption supplement . The controlled ovarian stimulation ( COH ) consist microdose GnRH agonist flare protocol , clinic 's standard protocol old woman . COH do use recombinant FSH ( Puregon ; Schering-Plough Inc. , Mississauga , ON , Canada ) human menopausal gonadotropin ( Menopur , Ferring Inc , Oakville , ON , Canada ) 150 unit twice daily S.C. Buserelin Acetate ( Superfact , Sanofi-Aventis Canada Inc , Laval , Quebec ) 0.05 mg subcutaneously B.I.D , continue day prior 10,000 unit human chorionic gonadotropin ( hCG ) ( Pregnyl , Organon ) . The dosage change must maintain duration study . Both drug continue daily follicular development consider adequate ( least 3 follicle &gt; 17 mm , E2 level acceptable number follicle present ) time hCG inject trigger final follicular maturation . Oocyte retrieval do 36 hour later vaginal ultrasound guide needle aspiration use local anesthesia mild sedation . At time retrieval , subject collect 2 mL saliva , addition , 2 mL follicular fluid collect first follicle aspirate ovary determination coQ10 activity arNOX assay . AS possible measure CoQ10 level single cell ( e.g . oocyte ) , FF represent direct cellular environment reflect metabolical profile cell . After retrieval , oocytes fertilize ICSI order contaminate maternal DNA polar body biopsy sample sperm DNA . On follow day , oocytes 2 pronucleus undergo biopsy one polar body . Polar body biopsy The oocyte inseminate use intracytoplasmic sperm injection ( ICSI ) technique keep culture incubator . In order biopsy polar body , oocyte hold hold pipette polar body 11-12 o'clock position . An opening make zona pellucida polish glass needle introduce perivitelline space polar body carefully remove . The embryo transfer perform morning third day egg retrieval . Polar body wash droplet isotonic HEPES-buffered saline transfer hypotonic solution , fix methanol : acetic acid glass slide , dehydrate methanol genetic analysis . The whole procedure adversely affect either fertilization cleavage rate biopsied oocyte , polar body involve processes.Karyotyping : The polar body transfer UHN microarray center chromosome number determination . The analysis do commercial kit Advalytix ( Olympus Life Science Research , Munich , Germany ) . This multiplex PCR base kit provide fast accurate count 23 chromosome tailor polar body chromosome count . After 2 day single embryo normal karyotype transfer uterine cavity ultrasound guidance use Cook transfer catheter ( Cook , Sidney , Australia ) . The rest viable embryo normal karyotype frozen ( Slow freezing ) . Luteal support consist progesterone suppository 100mg ( Kingsway Pharmacy , Toronto , Ontario Canada ) vaginally 3 time day start day transfer continue 2 week end cycle serum beta hCG drawn pregnant , CoQ10/ placebo discontinue . If pregnant , luteal support continue 10 week gestation . If patient pregnant cycle endometrial stimulation micronized estradiol , follow progesterone sufficient endometrial thickness measure . Four day afterwards , 1-2 embryo thaw transfer . Luteal support include estradiol progesterone maintain 10 week pregnant . These cycle freeze embryo transfer continue long frozen embryo retrieval . The study endpoint : 1 . Primary outcome measure number percentage euploid egg per retrieval 2 . Secondary outcome measure include : - Ovarian response - Embryo quality - Cumulative pregnancy rate / retrieval - Cumulative live birth rate / retrieval - CoQ10 activity saliva follicular fluid arNOX assay Coenzyme Q10 assay arNOX coenzyme Q10-inhibited , aging-related external NADH oxidase ( ECTO-NOX ) protein cell surface also present serum saliva . It capable superoxide generation measure superoxide dismutase-inhibited reduction ferricytochrome c ( Oxidaised cytochrome C ) . arNOX activity saliva old individual inhibit coenzyme Q10 . The activity first appear age 30 near maximum age 55. arNOX activity assay measurement superoxide production base standard method reduction ferricytochrome c superoxide monitor increase absorbance 550 nm reference 540 nm . As check specificity arNOX activity , superoxide dismutase ( SOD ) add near end assay ascertain rate return base line . The assay consist 150 μl ( 2 mg/ml ) oxidize ferricytochrome c solution 200 μl saliva add 2.5 ml assay buffer ( 8.06 g NaC1 , 0.2 g KC1 , 0.18 g Na 2HPO4 , 0.26 g KH2PO4 , 0.13 g CaCl2 , 0.1 g MgCl2 , 1.35 g glucose dissolve 1000 ml deionized water , adjust pH 7.4 , filter stored 4◦C ) . Rates determine use spectrophotometer dual wavelength mode continuous measurement ( 1 min every 1.5 min ) . After 45 min , 60 μl ( contain 60 unit ) SOD add assay continue additional 45 min . Salivary arNOX find convenient non-invasive method monitor arNOX level clinical coenzyme Q10 intervention trial response level parallel see serum cellular arNOX ( Morre Morre 2008 ) . Study population A total 54 female patient desire pregnancy enrol study TCART- Toronto Center Advanced Reproductive Technology . Each subject must meet study inclusion exclusion criterion Power calculation : A total 54 patient enter two treatment parallel-design study . The probability 90 percent study detect treatment difference two side p-value ≤ 0.01 , true difference treatment aneuploidy rate 25 % . This base assumption standard deviation response variable 0.180 . Assignment treatment randomization : Patients assign chronological order day study enrollment computer generate randomization . Each enrol participant receive pre-assigned package contain either placebo CoQ10 duration study . The physician blind assignment patient . Randomization do prior start first cycle . The investigator keep separate record relate name subject code number , allow easy check data subject file require . Statistical analysis do student t-test camper treatment placebo group outcome measure . Power analysis calculate alpha &lt; 0.01 . Anticipated outcomes potential pitfall . The number patient need study reasonable expect obstacle . If result study animal study able show significant difference number euploid embryos test control group , well outcome parameter . We work several month UHN microarray lab optimize use Advalytics multiplex PCR kit currently work well . We expect problem component object .</detailed_description>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<mesh_term>Fertility Agents</mesh_term>
	<criteria>Age 3543 year time enrollment Diagnosis primary infertility Body mass index ( BMI ) &gt; 38 kg/m2 Early follicular phase ( day 24 ) serum FSH level &gt; 20 mIU/ml . Abnormal uterine cavity evidence sonohysterogram hysterosalpingography Any current use systemic steroid medication infertility treatment within 3 month study enrollment . Any contraindication pregnant carry pregnancy term . Contraindication use CoQ10 , Superfact , Puregon , hCG , Estrace Progesterone suppository . Any ovarian abdominal abnormality may interfere adequate TVS evaluation . Absence one two ovary Clinically relevant systemic disease ( e.g. , Insulindependent diabetes , adrenal dysfunction , organic intracranial lesion , polycystic ovarian syndrome , hyperprolactinemia , hypothalamic tumor ) serious illness ( Neoplasia ) . History ( within past 12 month ) current abuse alcohol drug . Administration investigational drug within three month prior study enrollment . Any medical condition may interfere absorption , distribution , metabolism excretion study drug , gastrointestinal disease , mal absorption syndrome liver dysfunction Unexplained gynecological bleeding . Ejaculated sperm sufficient ICSI Patient able communicate adequately investigator comply requirement entire study . Abnormal COH screen blood do partner , include : prolactin , thyroid stimulate hormone , HIV serology , Hepatitis B C serology , Rubella , group screen syphilis serology prior participation study . Unwillingness give write informed consent . Previous entry study simultaneous participation another clinical trial . The concurrent use follow drug : Daunorubicin , Doxorubicin , Blood Pressure Medications , Warfarin , Timolol , atorvastatin , cerivastatin , lovastatin , pravastatin , simvastatin gemfibrozil , tricyclic antidepressant medication ( include amitriptyline , amoxapine , clomipramine , desipramine , doxepin , imipramine , nortriptyline , protriptyline , trimipramine ) multivitamins vitamin supplementation except Folic acid .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Mitochondrial dysfunction</keyword>
	<keyword>Mitochondrial nutrient</keyword>
	<keyword>Aneuploidy</keyword>
	<keyword>Meiotic Spindle</keyword>
	<keyword>Coenzyme Q10</keyword>
	<keyword>Electron transfer chain</keyword>
</DOC>